Table 1.

Clinical characteristics of study subjects.

N	57
Age, years	43.5 ± 10.1
Sex, men/women	19/38
DM duration, years	5.3 ± 4.0
HbA1C, %	8.6 ± 1.6
BMI, kg/m2	34.2 ± 4.1
Body weight, kg	92.6 ± 16.4
Subcutaneous fat area, cm2	344.0 ± 119.2
Visceral fat area, cm2	182.7 ± 55.8
Fasting C-peptide, ng/mL	6.9 ± 4.4
Stimulated C-peptide, ng/mL	9.3 ± 6.3
Treatment, n (%)
Oral hypoglycemic agents	35 (61%)
Insulin	22 (39%)